Abstract
AimsThere is a lack of biomarkers validated for assessing clinical deterioration in patients with COVID-19 on presentation to secondary or tertiary care. This evaluation looked at the potential clinical application...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have